Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy

被引:36
作者
Zeidan, Amer
Sham, Ronald
Shapiro, Joel
Baratta, Anthony
Kouides, Peter
机构
[1] Rochester Gen Hosp, Dept Internal Med, Rochester, NY 14621 USA
[2] Rochester Gen Hosp, Dept Hematol & Oncol, Rochester, NY 14621 USA
[3] Rochester Gen Hosp, Dept Pathol, Rochester, NY 14621 USA
[4] Rochester Gen Hosp, Dept Gastroenterol, Rochester, NY 14621 USA
关键词
D O I
10.1080/10428190701345433
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
引用
收藏
页码:1410 / 1413
页数:4
相关论文
共 19 条
[1]
Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome:: report on a series of 21 patients [J].
Belhadj, K ;
Reyes, F ;
Farcet, JP ;
Tilly, H ;
Bastard, C ;
Angonin, R ;
Deconinck, E ;
Charlotte, F ;
Leblond, V ;
Labouyrie, E ;
Lederlin, P ;
Emile, JF ;
Delmas-Marsalet, A ;
Arnulf, B ;
Zafrani, ES ;
Gaulard, P .
BLOOD, 2003, 102 (13) :4261-4269
[2]
Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO
[3]
2-Z
[4]
Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study [J].
Biancone, L ;
Orlando, A ;
Kohn, A ;
Colombo, E ;
Sostegni, R ;
Angelucci, E ;
Rizzello, F ;
Castiglione, F ;
Benazzato, L ;
Papi, C ;
Meucci, G ;
Riegler, G ;
Petruzziello, C ;
Mocciaro, F ;
Geremia, A ;
Calabrese, E ;
Cottone, M ;
Pallone, F .
GUT, 2006, 55 (02) :228-233
[5]
CALLEGARI P, 2006, CENTOCOR INC IMPORTA
[6]
Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease [J].
Corken Mackey, Ann ;
Green, Lanh ;
Liang, Li-ching ;
Dinndorf, Patricia ;
Avigan, Mark .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 44 (02) :265-267
[7]
CROHN BB, 1949, REGIONAL ILEITIS
[8]
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial [J].
Hanauer, SB ;
Feagan, BG ;
Lichtenstein, GR ;
Mayer, LF ;
Schreiber, S ;
Colombel, JF ;
Rachmilewitz, D ;
Wolf, DC ;
Olson, A ;
Bao, WH ;
Rutgeerts, P .
LANCET, 2002, 359 (9317) :1541-1549
[9]
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine [J].
Kandiel, A ;
Fraser, AG ;
Korelitz, BI ;
Brensinger, C ;
Lewis, JD .
GUT, 2005, 54 (08) :1121-1125
[10]
Khan WA, 2001, AM J CLIN PATHOL, V116, P41